Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 b... Read more
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for PF-07307405, the companies’ 6-valent outer sur... Read more
-Enigma Biomedical USA (EB USA) today announced the U.S. Food and Drug Administration (FDA) approval of TAUKLARIFY™ (florquinitau F 18 injection, also previously referred to as MK-6240), a radiodiagnostic agent indicated for positron emission... Read more
Nanochon, a medical device company developing Chondrograft, a novel patented implant for the treatment of articular cartilage defects of the knee, announced that it has received regulatory approval from Panamá's Ministry of Health to initiat... Read more
Aurisco Pharmaceutical, a leading global Oligonucleotide and Peptide (TIDES) manufacturer, announced that its site in Yangzhou, China has passed the USFDA inspection as the first generic Oligonucleotide API manufacturer in the world. The USFDA pre-a... Read more
In a major healthcare fraud enforcement action, Veloxis Pharmaceuticals will pay over million and accept a stringent deferred prosecution agreement after admitting illegal conduct tied to Envarsus XR in a case brought by two leading qui t... Read more
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced that the Biomedical Advanced Research and Develop... Read more
PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, announced the upcoming availability of SPRQ-Nx chemistry and an accompanying software update for its Vega systems. Together, the updates expand the range o... Read more
Reached a long-term business cooperation with a large pharmaceutical company to help it promote production licensing and commercial supervision and approval in major markets. Customers choose AGC Biologics Yokohama's new base to promote five com... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
